SCHEMBL86936

SCHEMBL86936

CN(C)C(=O)C(=O)NCC1CCn2c(nc(C(=O)NCc3ccc(F)cc3)c(O)c2=O)CO1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.56
KCNH2 Q12809 1/20 0.51
KCNE1 P15382 1/20 0.41
CCR1 P32246 1/20 0.41
KCNQ1 P51787 1/20 0.41
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.37
CALCA P06881 1/20 0.36
ALDH1A1 P00352 3/20 0.36
NPSR1 Q6W5P4 3/20 0.35
LMNA P02545 3/20 0.35
TSHR P16473 3/20 0.35
GAA P10253 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 1/20 0.35
MAPK1 P28482 1/20 0.35
KMT2A Q03164 1/20 0.35
ERCC1 P07992 1/20 0.35
FEN1 P39748 1/20 0.35
ERCC4 Q92889 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13661699 1.00 CYP2C9 (0.56) CYP2C9KCNH2KCNE1CCR1KCNQ1
SCHEMBL87854 0.85 CYP2C9 (0.58) CYP2C9KCNH2KCNE1CCR1KCNQ1
SCHEMBL13661700 0.85 KCNH2 (0.50) CYP2C9KCNH2KCNE1CCR1KCNQ1
SCHEMBL87288 0.82 KCNH2 (0.44) CYP2C9KCNH2KCNE1CCR1KCNQ1
SCHEMBL13691714 0.79 CYP2C9 (0.52) CYP2C9KCNH2KCNE1CCR1KCNQ1
SCHEMBL2205290 0.78 CYP2C9 (0.58) CYP2C9KCNH2KCNE1CCR1KCNQ1
SCHEMBL13691688 0.78 CYP2C9 (0.51) CYP2C9KCNH2KCNE1CCR1KCNQ1
SCHEMBL1375850 0.78 KCNH2 (0.58) CYP2C9KCNH2KCNE1CCR1KCNQ1
SCHEMBL13691813 0.78 CYP2C9 (0.51) CYP2C9KCNH2KCNE1CCR1KCNQ1
SCHEMBL13691733 0.78 CYP2C9 (0.47) CYP2C9KCNH2MAPTLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129398-B2 HIV integrase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-06 US disclosed
WO-2009117540-A1 BRIDGED HETEROCYCLES AS HIV INTEGRASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-09-24 WO disclosed